← All trials
NCT02308553
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2015
- Primary completion
- Mar 1, 2018
- Completion date
- Mar 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 126
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of Duisburg-EssenLead sponsor
- Alcedis GmbHCollaborator
- Boehringer IngelheimCollaborator
- MedacCollaborator
- University of Duisburg-EssenOverall official - principal investigator
- University of Duisburg-EssenSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.